Substance-specific Intermediate Phenotypes
Substance Abuse and Addiction Core: Tier 1 Substance Abuse and Addiction Core: Tier 2 Assessment of Substance Use and Substance Use Disorders Substance-specific Intermediate Phenotypes Substance Use-related Neurobehavioral and Cognitive Risk Factors Substance Use-related Psychosocial Risk Factors Substance Use-related Community Factors Substance Use-related Co-morbidities and Health-related Outcomes
| Select | Protocol | ID |
|---|---|---|
|
#520103 |
|
|
#520102 |
|
|
#520101 |
|
|
#520104 |
|
|
#520202 |
|
|
#520201 |
|
|
#520406 |
|
|
#520402 |
|
|
#520404 |
|
|
#520405 |
|
|
#520407 |
|
|
#520501 |
|
|
#520506 |
|
|
#520504 |
|
|
#520502 |
|
|
#520307 |
|
|
#520301 |
|
|
#520302 |
|
|
#520303 |
|
|
#520304 |
|
|
#520306 |
Release Date:
February 24, 2012; reviewed November 21, 2016
Scope of Collection
| Element Considered | Final Measures in Toolkit |
|---|---|
| Sensitivity | Acute Subjective Response to Substances - Current - General |
| Acute Subjective Response to Substances - Current - Specific - Alcohol | |
| Acute Subjective Response to Substances - Current - Specific - Drugs | |
| Acute Subjective Response to Substances - Current - Specific - Tobacco | |
| Acute Subjective Responses to Substances - Retrospective - Alcohol | |
| Acute Subjective Responses to Substances - Retrospective - Tobacco | |
| Core features of dependence | Self-reported Craving - General |
| Self-reported Craving - Specific - Alcohol | |
| Self-reported Craving - Specific - Cocaine | |
| Self-reported Craving - Specific - Heroin | |
| Self-reported Craving - Specific - Marijuana | |
| Self-reported Craving - Specific - Tobacco | |
| Cognitive processes indicative (predictive) of drug dependence | Expectancies - Alcohol, Cigarette Smoking, and Other Smoking - Alcohol |
| Expectancies - Alcohol, Cigarette Smoking, and Other Smoking - Illegal Stimulant Drugs | |
| Expectancies - Alcohol, Cigarette Smoking, and Other Smoking - Marijuana | |
| Expectancies - Alcohol, Cigarette Smoking, and Other Smoking - Prescription Stimulant Drugs | |
| Expectancies - Alcohol, Cigarette Smoking, and Other Smoking - Tobacco | |
| Motives - Alcohol, Tobacco and Other Substances - General | |
| Motives - Alcohol, Tobacco and Other Substances - Specific - Drugs | |
| Motives - Alcohol, Tobacco and Other Substances - Specific - Tobacco | |
| Motives - Alcohol, Tobacco, and Other Substances - Specific - Alcohol |
Working Group Roster:
WG Members:
|
Harriet de Wit, PhD, Co-Chair University of Chicago Chicago, IL |
Stephanie S. O'Malley, PhD, Co-Chair Yale University Department of Psychology New Haven, CT |
|
Kathleen Bucholz, PhD Washington University in St. Louis St. Louis, MO |
Dan Falk, PhD National Institute on Alcohol Abuse and Alcoholism (NIAAA) Bethesda, MD |
|
Hank Kranzler, MD University of Pennsylvania Philadelphia, PA |
Kenzie Preston, PhD National Institute on Drug Abuse (NIDA) NIDA Intramural Research Program Rockville, MD |
|
Ken Winters, PhD University of Minnesota, Twin Cities Minneapolis, MN |
Substance Abuse and Addiction Panel Liaison, WG Manager and WG Supervisor:
|
Arpana Agrawal, PhD, SAA Scientific Panel Liaison Washington University in St. Louis St. Louis, MO |
Kevin P. Conway, PhD, SAA Scientific Panel Liaison National Institute on Drug Abuse (NIDA) Division of Epidemiology, Services, and Prevention Research Rockville, MD |
|
Dana B. Hancock, PhD, WG Supervisor RTI International Research Triangle Park, NC |
Michael Phillips, MS, WG Manager RTI International Research Triangle Park, NC |
Supplemental Information includes protocols that the Working Group or Expert Review Panel considered useful and highly relevant to the domain but do not meet the criteria for inclusion in the Toolkit.
Substance-specific Intermediate Phenotypes Supplemental Information includes:Additional Information:
There is no additional information for this collection.